Evidence map›Paper›PMID 41822023›Full record

ArticleThe EPMA journal2026

Innovative mitochondria-based holistic 3PM approach to female health status: Facts and outlook.

Martin Pesta, Vadim Goncharenko, Vlastimil Kulda, Jiri Polivka, Jasur Rizaev, Olga Golubnitschaja

Abstract read
In one paragraph

Article in The EPMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martin PestaDepartment of Biology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
Vadim GoncharenkoGynecologic Department, Clinical Hospital "Pheophania", Kyiv, Ukraine.
Vlastimil KuldaDepartment of Medical Chemistry and Biochemistry, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
Jiri PolivkaDepartment of Immunochemical Diagnostics, University Hospital Pilsen, Pilsen, Czech Republic.
Jasur RizaevSamarkand State Medical University, Samarkand, Uzbekistan.
Olga GolubnitschajaPredictive, Preventive and Personalised (3P) Medicine, Department of Radiation Oncology, University Hospital Bonn, Rheinische Friedrich-Wilhelms- Universität Bonn, 53127 Bonn, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Throughout a woman's life, energy metabolism faces more volatile demands compared to men, driven by major hormonal transitions like puberty, the menstrual cycle, pregnancy, and menopause. Mitochondria, as central organelles for energy production and vital cellular biosensors, are consequently subjected to substantial physiological stress. When the body's compensatory mechanisms are overwhelmed, particularly in states of suboptimal health, compromised mitochondrial functionality is characterised by increased generation of reactive oxygen species (ROS) frequently associated with a chronification of the low-grade inflammation and development of follow-up pathologies. Compromised health and shifted homeostasis of mitochondria are crucial for development and progression of a broad spectrum of disorders in female subpopulations which can be exemplified by chronic fatigue, gestational diabetes mellitus, preeclampsia, polycystic ovary syndrome, and gynaecologic cancers, amongst others. This article strongly advocates for the implementation of an innovative, mitochondria-based holistic approach within the framework of Predictive, Preventive, and Personalised Medicine (3PM). 3PM-guided strategy focuses on the early detection of reversible health damage shifting care from reactive treatment to individualised proactive, risk-adapted management of the health conditions. The integration and interpretation of the multimodal data, supported by artificial intelligence, enable the stratification of individuals in suboptimal health conditions and affected patients for cost-effective protective measures tailored to individualised patient profiles, therapeutic interventions, and personalised pre- and rehabilitation programmes. In summary, by utilising mitochondrial biosensorics for monitoring systemic effects in a holistic manner, the presented 3PM-guided innovation offers a robust model for protecting individuals against health-to-disease transition and disease progression in affected patient cohorts.

Indexed as

AIChronic fatigueChronic inflammationExpert recommendationsFemale cancersFlammer syndrome phenotypeGestational diabetesHealth risk assessmentHomeostasisHormonal stressIndividualised protection against health-to-disease transitionIndividualised rehabilitation programmeLife qualityMitochondrial healthPatient-friendly non-invasive approachPatient phenotyping and stratificationPredictive preventive personalised medicine (PPPM / 3PM)PregnancySympathetic overdriveTear fluid analysis

Identifiers

PMID41822023
PMCPMC12976226

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.